What to know about Medicaid as Republicans consider cuts
Medicaid, the state-federal health insurance program for people with low incomes or disabilities, touches millions of Americans and has become deeply woven into the U.S. health care system.
Medicare
Trump administration pauses federal grants
The Trump administration has paused all federal grants and loans and while it will not pause Social Security or Medicare benefits, there is a temporary hold on all programs related to DEI, the Green New Deal and foreign aid assistance. CBS News correspondent Natalie Brand has more.
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
Here's what to know about Medicare's new $2,000 prescription drug cap
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.
The health stories that shaped 2024
2024 was a year of historic health headlines. From Ozempic to E. coli, CBS News medical contributor Dr. Céline Gounder joins to look back at the medical stories that defined the year.
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
New White House rule expands GLP-1 access
A New White House proposal would make Medicare and Medicaid cover GLP-1 weight loss drugs for people who are obese. The move would expand affordable access to the drugs to some 7.4 million people. Dr. Jon LaPook has more.
Doctor on Biden's GLP-1 drug coverage plan
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses whether the current or next administration can make this happen.
Behind Biden's weight loss drug proposal
President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the expansion.
Biden's weight loss drug coverage plan
President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.
Trump fills out picks to lead health agencies
President-elect Donald Trump is rounding out his Cabinet with several choices to lead the nation's top health agencies. Dr. Richard Besser, former acting director of the Centers for Disease Control and Prevention, joins CBS News to examine Trump's picks.
Doctor answers latest medical questions
Cases of several dangerous bacterial infections and viruses have been growing around the U.S. CBS News medical contributor Dr. Celine Gounder answers questions about these health concerns. She also discusses President-elect Donald Trump's choice of Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services.
Trump taps Dr. Mehmet Oz to lead key Medicare and Medicaid agency
Dr. Mehmet Oz unsuccessfully ran for Senate in 2022. Now he's Trump's choice to lead the Centers for Medicare and Medicaid Services.
Trump names RFK Jr. as his pick to run HHS
President-elect Donald Trump on Thursday named Robert F. Kennedy Jr. as his pick to lead the Department of Health and Human Services. If confirmed, Kennedy would be in charge of the Centers for Disease Control and Prevention, National Institutes of Health, Centers for Medicare and Medicaid Services and the Food and Drug Administration. CBS News political reporter Olivia Rinaldi has more.
Seniors will pay more for Medicare in 2025. Here's what to know.
Medicare's Part B monthly premium is outpacing both inflation and Social Security's cost-of-living adjustment.
Trump's White House return poised to tangle health care safety net
Former President Donald Trump's election victory and looming return to the White House will likely bring changes that scale back the nation's public health insurance programs.
Election outcome could bring big changes to Medicare
How the U.S. election plays out could have a major impact on the millions of Americans enrolled in Medicare. Here's what to know.
How Harris and Trump's stances on Medicare compare
The future of Medicare continues to come up in the closing arguments from both Kamala Harris and Donald Trump ahead of Election Day 2024.
Medicare Advantage plans get billions for dubious diagnoses: Report
Medicare Advantage plans run by private insurers are reaping billions by making home visits for senior citizens.
Biden highlights drug price reductions with New Hampshire visit
President Biden is visiting New Hampshire on Tuesday to tout his health care achievements and put focus on his policy legacy.
Medicare drug plans are getting better next year. Some will also cost more.
Although millions of Medicare recipients could see big drug savings in 2025, many insurers plan to raise their premiums. Here's what to know.
What is Harris' "Medicare at Home" plan and how would it work?
Kamala Harris says she would expand Medicare to cover in-home senior healthcare costs.
Kamala Harris proposes Medicare pay for more in-home health care
Still, Vice President Kamala Harris "The View" co-hosts that "not a thing" comes to mind that she would do differently than President Biden.
Vance asked about Trump's health care plans
One of the top problems facing Americans is the high cost of health care. At the last presidential debate, former President Donald Trump said he had "concepts of a plan" for replacing the Affordable Care Act. Watch Ohio Sen. JD Vance and Minnesota Gov. Tim Walz discuss their campaigns' health proposals.
Reduced Medicare drug prices: What to know
On Thursday, the Biden administration announced lower costs for 10 prescription drugs following the first-ever round of price negotiations between Medicare and pharmaceutical companies. CBS News medical contributor Dr. Celine Gounder joins to dive into the price cuts.
Interactive
These documents tell the story of the Cornell rape allegations
Hurricane Isaias threatens Gulf Coast with rain, flooding. See its path.
Fort Hood shooter's execution will be livestreamed, Pentagon says
Live
Trump promises not to resume Iran strikes before midterm elections
First on CBS
Trump aide's daughter pictured with pro-Russia politician
Guilfoyle associate says when she asked him for $100K, it was "quid pro quo"
El-Sayed and Rogers toss insults in Michigan Senate debate
Arizona congressional candidate reports rape while repairing campaign signs
